Notice Information
Notice Title
NHS National Generic Pharmaceuticals Wave 14a
Notice Description
NHS National Generic Pharmaceuticals Wave 14a:<br/>Potential periods of call-offs under the framework agreement:<br/>Hospital Only Products: DLN & DNW 01/02/2023 - 31/01/2025 (24 Months)<br/>Housekeeping Products (Hospital Only): CESW 01/02/2023 - 30/09/2023 (8 Months) LSNE 01/02/2023 - 31/05/2024 (16 Months)
Lot Information
5. Lot 2 - CM/PHG/22/5657/03 Housekeeping Products (Hospital Only): CESW & LSNE
Invitation to offer for NHS National Generic Pharmaceuticals Wave 14a
Offer reference number: CM/PHG/22/5657/03
Period of framework agreement: The total maximum duration of the framework agreement to be no more than 24 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months.
Potential periods of call-offs under the framework agreement:
Housekeeping Products (Hospital Only): CESW 01/02/2023 - 30/09/2023 (8 Months) LSNE 01/02/2023 - 31/05/2024
(16 Months) Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents
Options: Option or options to extend (at theAuthority's sole discretion) for a periodor periods up to a total of 48 months.
4. Lot 1 - CM/PHG/22/5657/02 Hospital Only Products: DLN & DNWInvitation to offer for NHS National Generic Pharmaceuticals Wave 14a
Offer reference number: CM/PHG/22/5657/02
Period of framework agreement: The total maximum duration of the framework agreement to be no more than 24 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months.
Potential periods of call-offs under the framework agreement:
Hospital Only Products: DLN & DNW 01/02/2023 - 31/01/2025 (24 Months) Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents
Options: Option or options to extend (at the Authority's sole discretion) for a period or periods up to a total of 48 months
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-h6vhtk-03688b
- Publication Source
- Find A Tender Service
- Latest Notice
- https://www.find-tender.service.gov.uk/Notice/001592-2023
- Current Stage
- Award
- All Stages
- Tender, Award
Procurement Classification
- Notice Type
- Award Notice
- Procurement Type
- Framework
- Procurement Category
- Goods
- Procurement Method
- Open
- Procurement Method Details
- Open procedure
- Tender Suitability
- Not specified
- Awardee Scale
- Large, SME
Common Procurement Vocabulary (CPV)
- CPV Divisions
33 - Medical equipments, pharmaceuticals and personal care products
-
- CPV Codes
33600000 - Pharmaceutical products
Notice Value(s)
- Tender Value
- £562,201,004 £100M-£1B
- Lots Value
- £562,201,004 £100M-£1B
- Awards Value
- Not specified
- Contracts Value
- £1
Notice Dates
- Publication Date
- 18 Jan 20233 years ago
- Submission Deadline
- 18 Oct 2022Expired
- Future Notice Date
- Not specified
- Award Date
- Not specified
- Contract Period
- Not specified - Not specified
- Recurrence
- Not specified
Notice Status
- Tender Status
- Complete
- Lots Status
- Cancelled
- Awards Status
- Active
- Contracts Status
- Active
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- NHS England
- Contact Name
- Available with D3 Tenders Premium →
- Contact Email
- Available with D3 Tenders Premium →
- Contact Phone
- Available with D3 Tenders Premium →
Buyer Location
- Locality
- LEEDS
- Postcode
- LS2 7UE
- Postcode Area
- Leeds
- Country
- England
-
- Major Region (ITL 1)
- TLE Yorkshire and The Humber
- Basic Region (ITL 2)
- TLE4 West Yorkshire
- Small Region (ITL 3)
- TLE42 Leeds
- Delivery Location
- Not specified
-
- Local Authority
- Leeds
- Electoral Ward
- Little London & Woodhouse
- Westminster Constituency
- Leeds Central and Headingley
Supplier Information
- Number of Suppliers
- 96
- Supplier Names
Mercury Pharmaceuticals Limited
Glenmark Pharmaceuticals Europe Ltd
Stirling Anglian Pharmaceuticals Ltd
Dr.Reddy's Laboratories (UK) Limited
MSN Laboratories Europe Limited
Sobi (Swedish Orphan Biovitrum Ltd)
Otsuka Pharmaceuticals UK Limited
Further Information
Open Contracting Data Standard (OCDS)
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.